The Associate Director of Oncology Policy Strategy leads the identification and analysis of policy changes affecting drug reimbursement and access to shape brand and business unit strategies. This role guides AstraZeneca's oncology policy and business strategy, focusing on federal (e.g., Inflation Reduction Act, CMS) and state policies.